TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
批准号:
3193405
负责人:
Satyabrata Nandi
金额:
$20.05万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1994-05-31
关键词:
athymic mouse bioassay breast neoplasms cell growth regulation cellular oncology chemical carcinogen chemical carcinogenesis female genetic markers growth factor hormone related neoplasm /cancer human tissue laboratory rat mammary epithelium molecular oncology natural gene amplification neoplasm /cancer genetics neoplastic cell nucleic acid probes preneoplastic state tissue /cell culture
中文摘要
我们的长期目标是诱发癌前病变和肿瘤
人乳腺上皮细胞的转化,定义如下
体外条件,含有直接和间接作用的化学物质
致癌物质。始终如一地改变人类乳房的能力
在确定的体外条件下的细胞对于设计是必不可少的
理解潜在细胞-分子事件的实验
人乳腺癌的转化和组织发生(S)。我们的
策略是将在血清中生长的人上皮细胞-
在胶原凝胶培养系统中的游离条件,以及在
使用各种基质的单层培养系统。具体来说,
我们将:a)分析正常、良性的生长规律
(纤维囊性)和癌性人乳腺细胞中的胶原
在激素存在的无血清条件下进行培养
(雌激素、黄体酮、催乳素等)、生长因子(EGF、
成纤维细胞生长因子、转化生长因子α、转化生长因子β等)和非激素性药物(脂类、
TPA,Li+);b)使用这些端点来设计文化条件
促进人乳腺上皮细胞转化的基因
高产,其方式类似于为
转化小鼠上皮细胞;c)使用cDNA探针
确定是否扩增、重排或表达
纤溶酶原激活物(tPA、尿激活酶)、转化生长因子α、转化生长因子β、表皮生长因子
谷胱甘肽-S-转移酶-P,γ-谷氨酰受体
转肽酶和0-6烷基-DNA-烷基转移酶是可靠的,
转化与肿瘤的定量分子标记物
组织发生;d)确定是否在分子水平上发生变化
与表型变化相关(核型、免疫细胞化学、
超微结构);e)建立适合体外和体内的检测方法
系统来识别那些分子细胞的变化,
代表癌前病变和肿瘤(恶性)转化子。
我们的经验和方法建议开发一个系统(S)
对人乳腺上皮细胞的体外转化是一种
可实现的目标。
英文摘要
Our long term objective is to induce preneoplastic and neoplastic
transformation of human mammary epithelial cells, under defined in
vitro conditions, with direct- and indirect-acting chemical
carcinogens. An ability to consistently transform human mammary
cells under defined in vitro conditions is essential to designing
experiments to understand the cellular-molecular events underlying
transformation and histogenesis of human breast cancer(s). Our
strategy is to transform human epithelial cells grown under serum-
free conditions in a collagen gel culture system, as well as in
monolayer culture systems using various matrices. Specifically,
we will: a) analyze the growth regulation of normal, benign
(fibrocystic) and carcinomatous human mammary cells in collagen
culture, under serum-free conditions in the presence of hormones
(estrogen, progesterone, prolactin, etc.), growth factors (EGF,
FGF, TGF alpha, TGF beta, etc.) and nonhormonal agents (lipids,
TPA, Li+); b) use these endpoints to design culture conditions
which facilitate human mammary epithelial cell transformation at
high yield, in a manner similar to those developed for
transformation of murine epithelial cells; c) use cDNA probes to
determine whether amplification, rearrangement or expression of
plasminogen activators (tPA, urokinase), TGF alpha, TGF beta, EGF
receptor, glutathione-s-transferase-P, gamma-glutamyl
transpeptidase and 0-6 alkyl-DNA-alkyltransferase are reliable,
quantitative molecular markers for transformation and tumor
histogenesis; d) determine whether changes at the molecular level
correlate with phenotype changes (karyotypic, immunocytochemical,
ultramicroscopic); e) develop suitable in vitro and in vivo assay
systems to identify those molecular-cellular changes which
represent preneoplastic and neoplastic (malignant) transformants.
Our experience and approach suggest that development of a system(s)
for transformation of human mammary epithelial cell in vitro is an
achievable goal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
-
批准号:6173700
-
项目类别:
-
资助金额:$21.83万
-
财政年份:1999
-
负责人:Satyabrata Nandi
-
依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
-
批准号:2849937
-
项目类别:
-
资助金额:$21.2万
-
财政年份:1999
-
负责人:Satyabrata Nandi
-
依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
-
批准号:6513247
-
项目类别:
-
资助金额:$23.16万
-
财政年份:1999
-
负责人:Satyabrata Nandi
-
依托单位:
PARITY RESISTANCE TO MAMMARY CANCER--MOLECULAR ANALYSES
-
批准号:6376792
-
项目类别:
-
资助金额:$22.49万
-
财政年份:1999
-
负责人:Satyabrata Nandi
-
依托单位:
MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION
-
批准号:2654238
-
项目类别:
-
资助金额:$26.44万
-
财政年份:1997
-
负责人:Satyabrata Nandi
-
依托单位:
MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION
-
批准号:2010668
-
项目类别:
-
资助金额:$25.41万
-
财政年份:1997
-
负责人:Satyabrata Nandi
-
依托单位:
MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION
-
批准号:2871907
-
项目类别:
-
资助金额:$27.17万
-
财政年份:1997
-
负责人:Satyabrata Nandi
-
依托单位:
MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION
-
批准号:6350200
-
项目类别:
-
资助金额:$28.54万
-
财政年份:1997
-
负责人:Satyabrata Nandi
-
依托单位:
MAMMARY CARCINOGENESIS IN RATS--HORMONAL PREVENTION
-
批准号:6150233
-
项目类别:
-
资助金额:$27.7万
-
财政年份:1997
-
负责人:Satyabrata Nandi
-
依托单位:
REGULATION OF MAMMARY CANCER BY HORMONES
-
批准号:2105173
-
项目类别:
-
资助金额:$34.89万
-
财政年份:1994
-
负责人:Satyabrata Nandi
-
依托单位:
REGULATION OF MAMMARY CANCER BY HORMONES
-
批准号:2105172
-
项目类别:
-
资助金额:$33.46万
-
财政年份:1994
-
负责人:Satyabrata Nandi
-
依托单位:
REGULATION OF MAMMARY CANCER BY HORMONES
-
批准号:2376922
-
项目类别:
-
资助金额:$36.29万
-
财政年份:1994
-
负责人:Satyabrata Nandi
-
依托单位:
REGULATION OF MAMMARY CANCER BY HORMONES
-
批准号:2105171
-
项目类别:
-
资助金额:$32.32万
-
财政年份:1994
-
负责人:Satyabrata Nandi
-
依托单位:
REGULATION OF MAMMARY CANCER BY HORMONES
-
批准号:2667974
-
项目类别:
-
资助金额:$37.74万
-
财政年份:1994
-
负责人:Satyabrata Nandi
-
依托单位:
TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
-
批准号:3193404
-
项目类别:
-
资助金额:$19.7万
-
财政年份:1989
-
负责人:Satyabrata Nandi
-
依托单位:
TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
-
批准号:3193406
-
项目类别:
-
资助金额:$20.85万
-
财政年份:1989
-
负责人:Satyabrata Nandi
-
依托单位:
TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
-
批准号:3193402
-
项目类别:
-
资助金额:$19.63万
-
财政年份:1989
-
负责人:Satyabrata Nandi
-
依托单位:
TRANSFORMATION OF HUMAN BREAST EPITHELIAL CELLS IN VITRO
-
批准号:2093249
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1989
-
负责人:Satyabrata Nandi
-
依托单位:
LIPID TURNOVER & GROWTH OF NORMAL & TUMOR MAMMARY CELLS
-
批准号:3179734
-
项目类别:
-
资助金额:$15.37万
-
财政年份:1985
-
负责人:Satyabrata Nandi
-
依托单位:
LIPID TURNOVER & GROWTH OF NORMAL & TUMOR MAMMARY CELLS
-
批准号:3179736
-
项目类别:
-
资助金额:$19.24万
-
财政年份:1985
-
负责人:Satyabrata Nandi
-
依托单位:
国内基金
海外基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
-
批准号:41606166
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:彭吉星
-
依托单位: